Healthcare Unfiltered

Chadi sits down with Nina Sanford, MD, Chief of Gastrointestinal Radiation Oncology Service at UT Southwestern, to explore the evolving landscape of radiation therapy in upper and lower GI malignancies. They discuss how advances in systemic treatments are reshaping radiation strategies, current standards of care in colorectal, gastroesophageal, pancreatic cancers, and liver cancers, and the growing role of organ preservation and adaptive radiation in improving patient outcomes. Dr. Sanford al...

Chadi sits down with Amy Comander, MD, a breast cancer medical oncologist at Mass General Brigham Cancer Institute and author of “Paving Your Path Through Breast Cancer and Beyond,” to discuss how patients can take control of their health and quality of life after a breast cancer diagnosis. She shares the inspiration behind her book and offers a practical, lifestyle medicine–focused roadmap—covering nutrition, physical activity, sleep, stress management, and social connection—along with her “...

Chadi sits down again with Dr. Urvi Shah for an in-depth, evidence-driven exploration of the often confusing relationship between food and cancer. They dive into how nutritional research is actually conducted—and why it’s so challenging—while separating widely regarded myths from what high-quality data truly support, including nuanced discussions on processed foods, red meat, plant-based diets, ketogenic diets, intermittent fasting, and alcohol use. Dr. Shah also offers practical, science-bac...

Chadi sits down with Dr. William “Bill” Small, Jr., a nationally recognized radiation oncologist and cancer center director at Loyola University Chicago, to explore the evolution of radiation oncology from its historical foundations to its rapidly advancing future. They discuss cutting-edge developments including proton therapy, radiopharmaceuticals, and the growing integration of molecular tumor profiling with precision radiation techniques, as well as the field’s increasing collaboration wi...

Chadi sits down with Katherine Stueland, President and CEO of GeneDx, to explore how genomic sequencing is transforming the diagnosis of rare diseases—especially for pediatric patients who often endure years searching for answers. She discusses the company’s work analyzing the full genome to uncover gene–disease correlations, its efforts to bring advanced genetic testing directly into pediatricians’ offices through education and access initiatives, and how its massive rare-disease dataset is ...